Connect with us
European Gaming Congress 2024

Fintech PR

EvolutionIQ Expands MedHub: Active medical summarization transforms medical data into a competitive advantage

Published

on

evolutioniq-expands-medhub:-active-medical-summarization-transforms-medical-data-into-a-competitive-advantage

MedHub provides comprehensive medical synthesis that enables faster, smarter claims handling across lines of insurance

NEW YORK, Oct. 14, 2024 /PRNewswire/ — EvolutionIQ, the market-leading Claims Guidance platform, today announced the expansion of MedHub to all life, health, accident, and casualty lines of insurance. MedHub is the only active medical summarization solution that transforms medical data into a competitive advantage by engaging claims professionals with holistic, tactical insights.

Challenges in Existing Medical Summarization Tools

For every claim, claims handlers spend an average of 12.5 hours reviewing complex medical data from various sources, while managing increasingly overwhelming caseload volume. Claims professionals can spend days trying to decipher the case documents for a single claim, and medically-driven claims are only getting more complex.

Unfortunately, most medical summarization tools meant to ease this challenge rely on passive summary generation and rote risk reviews which, when overused, can erode claim professional proficiency.

EvolutionIQ’s MedHub leverages EvolutionIQ’s market-leading technology advantages in Claims Guidance and five years of experience putting tactical recommendations directly into the front lines of complex claim handling.

EvolutionIQ’s advanced capabilities make medical insights highly interactive for claim professionals. With MedHub’s adjuster-in-the-loop structure, the product ensures exceptionally useful summaries, clear claim synthesis, insights, and assessments while building claim handler proficiency.

This approach fosters critical thinking, deepens medical understanding, and leads to more informed decisions.

“MedHub enhances our claims professionals’ ability to deeply understand their claimants’ medical circumstances, and be a partner on their return to health journey. Using it inside our existing EvolutionIQ environment makes it a seamless expansion of our capabilities to better serve our claimants,” said Amanda Staples, Vice President, Head of Group Insurance Claims, Prudential.

The MedHub Solution

Advertisement

MedHub seamlessly ingests, processes, and extracts data from hundreds of records, transforming dense, varied types of raw medical data and documentation into tactical insights. EvolutionIQ’s solution enables claims professionals to make faster critical decisions through an adjuster-in-the-loop approach.

Claims professionals using MedHub explore medical timelines, uncover hidden connections, and engage with the raw medical data in a way that fosters true understanding and continues building medical proficiency. MedHub enables users to directly understand the records that generated the medical insights, with EvolutionIQ’s Click for Evidence functionality taking users from synthesis to evidence with a click.

Carriers using MedHub benefit from:

Accelerated Reviews: Quickly extract critical information from hundreds of pages of medical records.

Enhanced Expertise: Engage your team with a deeper understanding of medical conditions and their impact on claims.

Exceptional Outcomes: Claims handlers make faster, more informed decisions, leading to improved customer experiences and reduced operational costs.

“The risk with any passive medical summary tool is it invites a copy/paste approach to time savings, and can potentially hurt claims outcomes,” said Benjamin Berry, Chief Product Officer at EvolutionIQ. “MedHub is entirely different, actively engaging claims professionals in the medical synthesis itself with access to essential data, context, and a timeline for informed decision-making. MedHub’s focus on expert engagement is a pivotal component in EvolutionIQ’s vision to become the #1 trusted source of medical insights and analysis in the insurance industry.

With a lightweight design and configurable interface, MedHub can be enabled and operational for any insurance carrier within two weeks, post data onboarding.

About EvolutionIQ

EvolutionIQ pioneered Claims Guidance in 2019. Its explainable AI guides insurance claims professionals to their highest potential impact on claims, including specific Next Best Action guidance. EvolutionIQ improves the claimant experience and delivers better claim outcomes to claimants, carriers and their customers. EvolutionIQ serves the group disability, individual disability and workers’ compensation markets worldwide. EvolutionIQ’s AI native products have been adopted by 70% of the top 15 U.S. disability carriers and a growing list of workers’ compensation carriers. The New York-based company employs almost 200 staff across the United States, Europe and Australia. For more information, visit evolutioniq.com and follow the company on LinkedIn.

Advertisement

Media Contact
Jason Kapler
Vice President of Marketing
EvolutionIQ
(917) 740-5608
[email protected]

Logo – https://mma.prnewswire.com/media/1723642/EvolutionIQ_updated_Logo.jpg

CisionView original content:https://www.prnewswire.co.uk/news-releases/evolutioniq-expands-medhub-active-medical-summarization-transforming-medical-data-into-a-competitive-advantage-302275249.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Press Announcement: AIMed24 Announces Strategic Partnership with Frost & Sullivan

Published

on

press-announcement:-aimed24-announces-strategic-partnership-with-frost-&-sullivan

SAN ANTONIO, Oct. 17, 2024 /PRNewswire/ — AIMed24, the premier event for artificial intelligence and healthcare innovation, is excited to announce its strategic partnership with Frost & Sullivan. This collaboration will further enhance AIMed24’s mission to advance healthcare with cutting-edge AI technologies. The conference will take place from November 17-19, 2024, at the Caribe Royale Orlando.

With over 60 years of supporting client growth, Frost & Sullivan has established itself as a leader in growth strategy and innovation through its unique Ecosystem of Content, Community, and Coaching. Frost’s Growth Pipeline as a Service (GPaaS) empowers companies, governments, and investors to maximize their economic potential while navigating emerging trends and pursuing sustainable growth. This partnership aligns perfectly with AIMed24’s focus on future-proofing healthcare through innovation.

Dr. Anthony Chang, founder of AIMed and Chief Intelligence and Innovations Officer at Children’s Hospital of Orange County, said, “Partnering with Frost & Sullivan brings immense value to AIMed24. Their expertise in fostering growth and innovation across industries, including healthcare, complements our mission to lead the conversation on AI’s transformative impact on patient care. Together, we’re shaping the future of medicine with pioneering ideas and real-world solutions.”

Greg Caressi, Senior Vice President of Global Client Services at Frost & Sullivan, shared his enthusiasm, stating, “We are thrilled to partner with AIMed24, a conference that has consistently brought together the brightest minds in AI and healthcare. This partnership aligns with our commitment to creating opportunities for sustainable growth and innovation, and our focus on AI in healthcare and life sciences applications. We look forward to contributing to the exchange of knowledge that will inspire the next wave of healthcare advancements.”

AI Med, a leading event that brings together experts at the intersection of artificial intelligence and healthcare, will serve as a platform for Greg Caressi to share his deep expertise in digital health transformation and AI-driven healthcare innovations. As a recognized thought leader in healthcare technology and innovation, Greg has spent decades analyzing emerging trends and fostering strategic initiatives that enhance data transformation and utilization of data to drive health outcomes.

AIMed24 is the must-attend conference for healthcare professionals, AI innovators, and technology leaders. With strategic partnerships like Frost & Sullivan, this year’s event promises to deliver an immersive experience, featuring groundbreaking keynote speakers, hands-on workshops, and unparalleled networking opportunities. The collaboration highlights AIMed’s global impact, with representation from all five continents and over 50 countries throughout its history. Attendees will have the opportunity to learn from industry experts and gain insights into AI’s role in shaping the future of healthcare.

Why This Partnership Matters: AIMed24 is committed to building long-term partnerships with key organizations that share its vision of improving healthcare through AI. Frost & Sullivan’s expertise in identifying growth opportunities and their forward-looking approach to industry trends makes them an ideal partner. Together, AIMed24 and Frost & Sullivan will deliver a unique, high-value experience for attendees, ensuring they leave equipped with actionable strategies and insights to drive AI innovation in healthcare.

Scholarships and Global Representation: AIMed24 is proud to continue its tradition of supporting clinicians and students from around the world through special scholarships. This initiative ensures that financial barriers do not prevent the brightest minds from participating in this world-class event.

Register Today: Don’t miss out on AIMed24! To learn more about the event and secure your tickets, visit www.aimed.events.

About Frost & Sullivan
For over six decades, Frost & Sullivan has guided the world’s top companies toward transformational growth journeys that result in a stream of innovative growth opportunities. Frost’s Growth Pipeline as a Service (GPaaS) value proposition allows customers to maximize their economic potential, navigate emerging megatrends, and shape a future based on sustainable growth. Learn more.

Advertisement

About AIMed24
AIMed24 is where AI and medicine’s brightest minds converge to shape the future of healthcare. Join us at the Caribe Royale Orlando from November 17-19 for groundbreaking keynotes, hands-on workshops, and exceptional networking opportunities with industry leaders.

Founded by Dr. Anthony Chang, AIMed is a clinician-led community advancing AI in health. AIMed24 will showcase impactful smart healthcare solutions, facilitate connections with AI trailblazers, and engage with top institutions and innovators.

Be at the forefront of healthcare innovation. Learn more.

View original content:https://www.prnewswire.co.uk/news-releases/press-announcement-aimed24-announces-strategic-partnership-with-frost–sullivan-302279447.html

Continue Reading

Fintech PR

GenNx360 Capital Partners Enters Agreement to Sell ITsavvy to Xerox Holdings Corporation

Published

on

gennx360-capital-partners-enters-agreement-to-sell-itsavvy-to-xerox-holdings-corporation

NEW YORK, Oct. 17, 2024 /PRNewswire/ — GenNx360 Capital Partners (“GenNx360”), a New York-based private equity firm, is pleased to announce it has entered into a definitive agreement to sell its portfolio company, ITsavvy LLC (“ITsavvy” or “the Company”), a provider of end-to-end IT infrastructure solutions, to Xerox Holdings Corporation (“Xerox”). The transaction is expected to close following customary regulatory approvals.

ITsavvy is an Oak Brook, Illinois-based technology solutions and services provider that delivers frictionless IT experiences by designing, developing and delivering technology infrastructure solutions and services that accelerate business outcomes on behalf of its clients.

During GenNx360’s investment, the Company experienced impressive organic growth, completed an acquisition of a highly strategic AIOps-enabled managed services provider (“MSP”) and significantly increased overall profitability through a number of well-executed margin enhancement initiatives. A committed focus to the Company’s services strategy further fueled organic growth and strengthened the Company’s overall value proposition. Through the support of GenNx360, the Company also successfully launched an AI and Intelligent Automation strategy. This strategy included commercializing an AI offering to better serve the Company’s clients, as well as optimizing the Company’s internal operations.

“The success of our investment in ITsavvy is a testament to the  growth achieved during our partnership with management over the past two years. We are pleased with the Company’s transformation under our ownership and wish Munu and team all the best going forward,” said Ron Blaylock, GenNx360 Founder, Managing Partner, and Chairman of the ITsavvy Board of Directors.

“We appreciate GenNx360’s support and strategic insights over the past two years. They have been an outstanding partner to work with to enhance and evolve our platform,” said ITsavvy CEO, Munu Gandhi. “We are excited to join forces with a longstanding company in Xerox, one of the great global brands, and we look forward to supporting their next stage of growth.”

“As part of our Reinvention, we have created a greater organizational focus on our emerging IT Services capabilities,” said John Bruno, President and Chief Operating Officer at Xerox. “ITsavvy’s complementary offerings, combined with our reputation, position us to accelerate growth across key markets and unlock new opportunities to help clients transform the way they work.”

“It has been a privilege to work with Munu and the ITsavvy team over the past two years. We are incredibly proud of the Company’s growth and look forward to following their success in the future,” said Peter White, Principal at GenNx360 and ITsavvy Board Member.

Loeb & Loeb and Greenberg Traurig served as legal advisors to ITsavvy and GenNx360.

About ITsavvy LLC

ITsavvy is an industry-leading IT infrastructure solutions provider with comprehensive value added resell capabilities. Founded in 2004 in suburban Chicago, ITsavvy provides frictionless client experiences through the deployment of holistic solutions that deliver client business outcomes. For more information on ITsavvy, please visit www.itsavvy.com.

Advertisement

About GenNx360 Capital Partners

GenNx360 Capital Partners is a private equity firm focused on acquiring middle market business services and industrial companies. GenNx360 partners with companies having proven and sustainable business models in expanding industries with the objective of implementing and supporting value-enhancing organic and inorganic initiatives to accelerate growth, deliver cost efficiencies, and generate strong financial returns. GenNx360 was founded in 2006 and is headquartered in New York City.  For more information on GenNx360, please visit www.gennx360.com.

ITsavvy

For media inquiries about this press release, please contact:
Alicia Francis, Head of Investor Communications
[email protected]  
Phone: 929.287.6107

Logo – https://mma.prnewswire.com/media/792723/GenNx360_Logo_NEW.jpg
Logo – https://mma.prnewswire.com/media/1875809/ITsavvy_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/gennx360-capital-partners-enters-agreement-to-sell-itsavvy-to-xerox-holdings-corporation-302279302.html

Continue Reading

Fintech PR

Exponential Science Launches to Advance the Convergence of Blockchain with AI, and Other Deep Tech

Published

on

exponential-science-launches-to-advance-the-convergence-of-blockchain-with-ai,-and-other-deep-tech
  • Exponential Science, a global non-profit foundation supported by leading technology companies like Hedera, drives innovation in emerging technologies to tackle complex challenges and deliver groundbreaking solutions.
  • With global operations, the Foundation fosters open collaboration and co-creation between academia, industry, government, the open-source community, and startups.
  • The launch details were announced on stage during the exclusive 10th annual P2P Financial Systems International Workshop, in Dubai.

DUBAI, UAE, Oct. 17, 2024 /PRNewswire/ — Dr. Paolo Tasca, Founder and Chairman, and Nikhil Vadgama, Founder and Director, have launched Exponential Science, a non-profit foundation, created to build on their legacy of leadership in the blockchain space through the DLT Science Foundation.

Exponential Science was established to address the growing interdependencies among emerging digital technologies and deep tech. It will focus on the complementarity of blockchain with other cutting-edge technologies, including artificial intelligence, quantum computing, AR/VR and other deep tech.

Exponential Science leverages the expertise of Dr. Tasca and Nikhil Vadgama. Tasca is a renowned professor and economist with an extensive background in distributed systems and digital innovation. He has advised organizations such as the United Nations and several central banks on CBDC and Fintech. He co-founded the UCL Centre for Blockchain Technologies and also co-founded several top Web3 companies. Prof. Vadgama, has extensive experience in fintech, having launched innovative new businesses in multiple jurisdictions and worked with and advised a number of leading stakeholders, from industry participants to government officials. He is also an award-winning educator in the field of emerging technologies.

Both have witnessed the convergence of multiple emerging digital technologies, highlighting the need for interdisciplinary approaches to tackle complex societal and technological challenges. To address this, Exponential Science fosters open collaboration and co-creation among academia, industries, and government stakeholders. It also runs its cutting-edge science research department, comprised of renowned professors and visionary thinkers.

The team is made up of international academic and research experts from diverse fields and disciplines who are working on various initiatives, including the new MiCA Crypto Alliance, which helps blockchain and crypto businesses meet the EU’s incoming regulatory requirements. Other key projects include work with the UK CBT, the national research hub that drives the UK agenda for blockchain, and DLT Earth, an initiative seeking to advance climate research, sustainable finance, and ESG reporting methodologies.

The foundation’s upcoming plans include a range of initiatives aimed at expanding scientific impact and fostering collaboration across sectors.  Research and spinoff initiatives will target specific challenges, enabling the exploration of niche areas of innovation and accelerating progress in critical fields. Complementing these efforts, a robust content and event strategy will be implemented, creating a dynamic platform for knowledge sharing and collaboration.

Exponential Science is backed by Hedera, a high-performance, secure, and sustainable public DLT network governed by the world’s leading institutions. This backing enables Exponential Science to leverage extensive resources and expertise, further empowering its mission to drive interdisciplinary collaboration and deliver impactful solutions to societal challenges.

Dr Tasca said: “Our vision has always been about driving groundbreaking research and fostering collaboration across technological fields. With the launch of Exponential Science, we are expanding that vision to embrace a wider range of emerging technologies that are reshaping the digital landscape. We will navigate this fusion using a multi-disciplinary approach to explore how these technologies can work together to create solutions that address today’s most pressing challenges.”

Professor Vadgama commented: Exponential Science represents our commitment to exploring and addressing the interconnectedness of today’s technological landscape. By broadening our focus, we can leverage the combined power of multiple technologies to deliver transformative outcomes. Our objective is to empower open source communities and industries to thrive in this rapidly evolving landscape.”

About Exponential Science

Exponential Science is a not-for-profit foundation driven to advance research, education, and innovation across emerging digital technologies and deep tech. With a mission to explore the convergence of blockchain, Artificial Intelligence (AI), the Internet of Things (IoT), and other transformative technologies, Exponential Science drives interdisciplinary collaboration to deliver impactful solutions to challenges faced by society. It brings together stakeholders from academic institutions, regulators, and diverse industries to drive innovative research and collaboration. Exponential Science is committed to fostering sustainable, transparent, and innovative developments that will shape a more advanced and interconnected future. For more information go to: www.exponentialscience.org.

Advertisement

 

View original content:https://www.prnewswire.co.uk/news-releases/exponential-science-launches-to-advance-the-convergence-of-blockchain-with-ai-and-other-deep-tech-302279374.html

Continue Reading
Advertisement
Advertisement European Gaming Congress 2024

Latest news

Trending